Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 5 of 5 descriptions
No. | 薬物名(臨床試験情報から抽出) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Dulaglutide (Trulicity) | 1件: Dulaglutide Dulaglutide (Trulicity) | 1件: Dulaglutide
Dulaglutide
(Trulicity) 💬1. Dulaglutide
| 1件: GLP1R GLP1R 💬1. Dulaglutide
| 3件: Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 299 299 💬1. Dulaglutide
| ||||||||||||||
2 | Dulaglutide 0.75Mg/0.5Ml Inj Pen (Trulicity) | 1件: Dulaglutide Dulaglutide (Trulicity) | 1件: Dulaglutide
Dulaglutide
(Trulicity) 💬2. Dulaglutide 0.75Mg/0.5Ml Inj Pen
| 1件: GLP1R GLP1R 💬2. Dulaglutide 0.75Mg/0.5Ml Inj Pen
| 3件: Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 299 299 💬2. Dulaglutide 0.75Mg/0.5Ml Inj Pen
| ||||||||||||||
3 | Trulicity | 1件: Dulaglutide Dulaglutide (Trulicity) | 1件: Dulaglutide
Dulaglutide
(Trulicity) 💬3. Trulicity
| 1件: GLP1R GLP1R 💬3. Trulicity
| 3件: Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 13 13 💬3. Trulicity
| ||||||||||||||
4 | Trulicity 0,75 mg injekcný roztok naplnený v injekcnom pere | 1件: Dulaglutide Dulaglutide (Trulicity) | 1件: Dulaglutide
Dulaglutide
(Trulicity) 💬4. Trulicity 0,75 mg injekcný roztok naplnený v injekcnom pere
| 1件: GLP1R GLP1R 💬4. Trulicity 0,75 mg injekcný roztok naplnený v injekcnom pere
| 3件: Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 13 13 💬4. Trulicity 0,75 mg injekcný roztok naplnený v injekcnom pere
| ||||||||||||||
5 | Trulicity 0,75 mg injekcný roztok naplnený v injekcnom pere. | 1件: Dulaglutide Dulaglutide (Trulicity) | 1件: Dulaglutide
Dulaglutide
(Trulicity) 💬5. Trulicity 0,75 mg injekcný roztok naplnený v injekcnom pere.
| 1件: GLP1R GLP1R 💬5. Trulicity 0,75 mg injekcný roztok naplnený v injekcnom pere.
| 3件: Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 13 13 💬5. Trulicity 0,75 mg injekcný roztok naplnený v injekcnom pere.
|